Kreton Mavromatis MD
Overview
Dr. Mavromatis is a professor of medicine in the Division of Cardiology at Emory University. He is director of the cardiac catheterization laboratory at the Atlanta VA Medical Center. He also performs Transcatheter Valve and Structural Heart Disease Interventions at Emory University Hospital.
He obtained his MD degree from University of Michigan, completed his Internal Medicine training at the University of Washington, and completed his Cardiology and Interventional Cardiology training at Emory University in 2002.
Dr. Mavromatis also received a Howard Hughes Research Fellowship at the National Institutes of Health and performed a Basic Research fellowship at Emory University. He currently is an associate director of Interventional Cardiology Training Program. He has also been an investigator in a number of important clinical trials, including COURAGE, FREEDOM, FAME II, ISCHEMIA, PARACHUTE and PARTNER, and in several studies of adult stem cells and mental stress in cardiovascular disease.
Academic Appointment
- Professor of Medicine, Emory University School of Medicine
- Distinguished Physician, Emory University School of Medicine
- Associate Professor of Medicine, Department of Medicine, Emory University Department of Medicine
- Clinical Adjunct Assistant Professor of Medicine, Department of Medicine, Morehouse University School of Medicine
Education
Degrees
- MD from University of Michigan
- BS from University of Michigan
Research
Focus
- My major interest is the pathogenesis and treatment of coronary artery disease. This includes a specific interest in understanding the vascular injury and healing; the treatment of coronary artery disease with medications and percutaneous coronary interevention; and tissue regeneration in ischemic heart disease.
Publications
-
Outcomes after fractional flow reserve-guided percutaneous coronary intervention versus coronary artery bypass grafting (FAME 3): 5-year follow-up of a multicentre, open-label, randomised trial.
Lancet Volume: 405 Page(s): 1481 - 1490
04/26/2025 Authors: Fearon WF; Zimmermann FM; Ding VY; Takahashi K; Piroth Z; van Straten AHM; Szekely L; Davidaviius G; Kalinauskas G; Mansour S -
Invasive vs Conservative Management of Patients With Chronic Total Occlusion: ResultsFrom the ISCHEMIA Trial.
J Am Coll Cardiol Volume: 85 Page(s): 1335 - 1349
04/01/2025 Authors: Bangalore S; Mancini GBJ; Leipsic J; Budoff MJ; Xu Y; Anthopolos R; Brilakis ES; Dwivedi A; Spertus JA; Jones PG -
Guideline-Directed Medical Therapy and Outcomes in the ISCHEMIA Trial.
J Am Coll Cardiol Volume: 85 Page(s): 1317 - 1331
04/01/2025 Authors: Maron DJ; Newman JD; Anthopolos R; Lu Y; Stevens S; Boden WE; Mavromatis K; Linefsky J; Nair RG; Bockeria O -
Evaluating the Appropriate Use Criteria for Coronary Revascularization in Stable Ischemic Heart Disease Using Randomized Data From the ISCHEMIA Trial.
Circ Cardiovasc Qual Outcomes Volume: 18 Page(s): e010849
03/01/2025 Authors: Slater J; Maron DJ; Jones PG; Bangalore S; Reynolds HR; Fu Z; Stone GW; Kirby R; Hochman JS; Spertus JA -
Relationship Between Severity of Ischemia and Coronary Artery Disease for Different Stress Test Modalities in the ISCHEMIA Trial.
Circ Cardiovasc Interv Volume: 17 Page(s): e013743
12/01/2024 Authors: Reynolds HR; Page CB; Shaw LJ; Berman DS; Chaitman BR; Picard MH; Kwong RY; Min JK; Leipsic J; Mancini GBJ -
Impact of a Chronic Total Occlusion on Outcomes After FFR-Guided PCI or Coronary Bypass Surgery: A FAME 3 Substudy.
Circ Cardiovasc Interv Volume: 17 Page(s): e014300
11/01/2024 Authors: Otsuki H; Takahashi K; Zimmermann FM; Mavromatis K; Aminian A; Jagic N; Dambrink J-HE; Kala P; MacCarthy P; Witt N -
International Variation in Health Status Benefits in Patients Undergoing Initial Invasive Versus Conservative Management for Chronic Coronary Disease: Insights From the ISCHEMIA Trial.
Circ Cardiovasc Qual Outcomes Volume: 17 Page(s): e010534
10/01/2024 Authors: Ikemura N; Spertus JA; Nguyen D; Fu Z; Jones PG; Reynolds HR; Bangalore S; Bhargava B; Senior R; Elghamaz A -
Cardiometabolic Co-morbidity Burden and Circulating Biomarkers in Patients With Chronic Coronary Disease in the ISCHEMIA Trials.
Am J Cardiol Volume: 225 Page(s): 118 - 124
08/15/2024 Authors: Hamo CE; Liu R; Wu W; Anthopolos R; Bangalore S; Held C; Kullo I; Mavromatis K; McManus B; Newby LK -
Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial.
Circ Cardiovasc Interv Volume: 17 Page(s): e013435
06/01/2024 Authors: Praco R; Spertus JA; Broderick S; Bangalore S; Rockhold FW; Ruzyllo W; Demchenko E; Nageh T; Grossman GB; Mavromatis K -
Biomarkers and cardiovascular events in patients with stable coronary disease in the ISCHEMIA Trials.
Am Heart J Volume: 266 Page(s): 61 - 73
12/01/2023 Authors: Newman JD; Anthopolos R; Ruggles KV; Cornwell M; Reynolds HR; Bangalore S; Mavromatis K; Held C; Wallentin L; Kullo IJ